Nanjing Leads Biolabs

NCT07791758

Phase 1/2, Not yet recruiting, 2026, 369 people, 28 Aug 2026, clinicaltrials.gov

NCT07720193

Phase 3, Not yet recruiting, 2026, 280 people, 22 Jul 2026, clinicaltrials.gov

NCT07390383

Phase 2, Recruiting, 2026, 110 people, 5 Feb 2026, clinicaltrials.gov

NCT07331155

Phase 2, Recruiting, 2026, 110 people, 9 Jan 2026, clinicaltrials.gov

NCT07042802

Phase 1/2, Recruiting, 2025, 180 people, 29 Jun 2025, clinicaltrials.gov

NCT06783647

Phase 2, Recruiting, 2025, 250 people, 20 Jan 2025, clinicaltrials.gov

NCT06157827

Phase 1/2, Recruiting, 2023, 178 people, 6 Dec 2023, clinicaltrials.gov

NCT05516914

Phase 1/2, Completed, 2022, 98 people, 26 Aug 2022, clinicaltrials.gov